Table S1 study. (DOC) References 1000 Rads of c-IR in the presence or absence of 20 ug/mL CHX and immunoblotted for menin and Vinculin as a loading control. (TIF) Figure S5 Menin coimmunoprecipitation mass spec- trometry data. Endogenous menin was immunoprecipitated from untreated 293T cells or 6 hours after 1000 Rads of c-IR, or 2 hours after exposure to 25 J/m2 UV. The resulting immunopre- cipitates were resolved and prominent bands were excised for mass spectrometry. The identified peptides from KMT2A/KMT2D and subunits of RNA Polymerase II are shown. (TIF) Primers for qRT-PCR and ChIP used in this 1. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, et al. (1997) Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276: 404–407. 2. Lemmens I, Van de Ven WJ, Kas K, Zhang CX, Giraud S, et al. (1997) Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. Hum Mol Genet 6: 1177–1183. 3. Agarwal SK, Lee Burns A, Sukhodolets KE, Kennedy PA, Obungu VH, et al. (2004) Molecular pathology of the MEN1 gene. Ann N Y Acad Sci 1014: 189–198. 4. Debelenko LV, Brambilla E, Agarwal SK, Swalwell JI, Kester MB, et al. (1997) Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. Hum Mol Genet 6: 2285–2290. 5. Heppner C, Kester MB, Agarwal SK, Debelenko LV, Emmert-Buck MR, et al. (1997) Somatic mutation of the MEN1 gene in parathyroid tumours. Nat Genet 16: 375–378. 6. Zhuang Z, Vortmeyer AO, Pack S, Huang S, Pham TA, et al. (1997) Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. Cancer Res 57: 4682–4686. 7. Wautot V, Khodaei S, Frappart L, Buisson N, Baro E, et al. (2000) Expression analysis of endogenous menin, the product of the multiple endocrine neoplasia type 1 gene, in cell lines and human tissues. Int J Cancer 85: 877–881. 8. Guru SC, Crabtree JS, Brown KD, Dunn KJ, Manickam P, et al. (1999) Isolation, genomic organization, and expression analysis of Men1, the murine homolog of the MEN1 gene. Mamm Genome 10: 592–596. 9. Guru SC, Prasad NB, Shin EJ, Hemavathy K, Lu J, et al. (2001) Characterization of a MEN1 ortholog from Drosophila melanogaster. Gene 263: 31–38. 10. Wu X, Hua X (2008) Menin, histone h3 methyltransferases, and regulation of cell proliferation: current knowledge and perspective. Curr Mol Med 8: 805–815. 11. Dreijerink KM, Lips CJ, Timmers HT (2009) Multiple endocrine neoplasia type 1: a chromatin writer’s block. J Intern Med 266: 53–59. 12. Hughes CM, Rozenblatt-Rosen O, Milne TA, Copeland TD, Levine SS, et al. (2004) Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus. Mol Cell 13: 587–597. 13. Yokoyama A, Wang Z, Wysocka J, Sanyal M, Aufiero DJ, et al. (2004) Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression. Mol Cell Biol 24: 5639–5649. 14. Karnik SK, Hughes CM, Gu X, Rozenblatt-Rosen O, McLean GW, et al. (2005) Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c. Proc Natl Acad Sci U S A 102: 14659–14664. 15. Yokoyama A, Somervaille TC, Smith KS, Rozenblatt-Rosen O, Meyerson M, et al. (2005) The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis. Cell 123: 207–218. 16. Scacheri PC, Davis S, Odom DT, Crawford GE, Perkins S, et al. (2006) Genome-wide analysis of menin binding provides insights into MEN1 tumorigenesis. PLoS Genet 2: e51. 17. Agarwal SK, Impey S, McWeeney S, Scacheri PC, Collins FS, et al. (2007) Distribution of menin-occupied regions in chromatin specifies a broad role of menin in transcriptional regulation. Neoplasia 9: 101–107. 18. Yokoyama A, Cleary ML (2008) Menin critically links MLL proteins with LEDGF on cancer-associated target genes. Cancer Cell 14: 36–46. 19. Bres V, Yoshida T, Pickle L, Jones KA (2009) SKIP interacts with c-Myc and Menin to promote HIV-1 Tat transactivation. Mol Cell 36: 75–87. 20. Harper JW, Elledge SJ (2007) The DNA damage response: ten years after. Mol Cell 28: 739–745. Menin Is Phosphorylated in Response to DNA Damage Acknowledgments The authors would like to thank Drs. Steven Gygi and Woong Kim for help with mass spectrometry and Drs. Stephen Elledge, Shuhei Matsuoka, and Agata Smogorzewska for sharing DNA damage expertise. We would also like to thank Lear Brace and Drs. Hideo Watanabe, Peter Hammerman, Sue-Ann Woo and Jeonghee Cho for critical reading of this manuscript. We are grateful to E. McIntush at Bethyl Laboratories for help in antibody design and preparation, and R. Tomaino of the Taplin Biological Institute for Mass Spectrometry for mass spectrometry analysis. Author Contributions Conceived and designed the experiments: JF WL OR-R MM. Performed the experiments: JF. Analyzed the data: JF WL OR-R MM. Contributed reagents/materials/analysis tools: JF OR-R. Wrote the paper: JF MM. 21. Jin S, Mao H, Schnepp RW, Sykes SM, Silva AC, et al. (2003) Menin associates with FANCD2, a protein involved in repair of DNA damage. Cancer Res 63: 4204–4210. 22. Kottemann MC, Bale AE (2009) Characterization of DNA damage-dependent cell cycle checkpoints in a menin-deficient model. DNA Repair (Amst) 8: 944–952. 23. Bazzi W, Renon M, Vercherat C, Hamze Z, Lacheretz-Bernigaud A, et al. (2008) MEN1 missense mutations impair sensitization to apoptosis induced by wild-type menin in endocrine pancreatic tumor cells. Gastroenterology 135: 1698–1709 e1692. 24. Sukhodolets KE, Hickman AB, Agarwal SK, Sukhodolets MV, Obungu VH, et al. (2003) The 32-kilodalton subunit of replication protein A interacts with menin, the product of the MEN1 tumor suppressor gene. Mol Cell Biol 23: 493–509. 25. Marek LR, Kottemann MC, Glazer PM, Bale AE (2008) MEN1 and FANCD2 mediate distinct mechanisms of DNA crosslink repair. DNA Repair (Amst) 7: 476–486. 26. MacConaill LE, Hughes CM, Rozenblatt-Rosen O, Nannepaga S, Meyerson M (2006) Phosphorylation of the menin tumor suppressor protein on serine 543 and serine 583. Mol Cancer Res 4: 793–801. 27. Vousden KH, Prives C (2009) Blinded by the Light: The Growing Complexity of p53. Cell 137: 413–431. 28. Scacheri PC, Rozenblatt-Rosen O, Caplen NJ, Wolfsberg TG, Umayam L, et al. (2004) Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells. Proc Natl Acad Sci U S A 101: 1892–1897. 29. Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER, 3rd, Hurov KE, et al. (2007) ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316: 1160–1166. 30. Stokes MP, Rush J, Macneill J, Ren JM, Sprott K, et al. (2007) Profiling of UV- induced ATM/ATR signaling pathways. Proc Natl Acad Sci U S A 104: 19855–19860. 31. Yaguchi H, Ohkura N, Takahashi M, Nagamura Y, Kitabayashi I, et al. (2004) Menin missense mutants associated with multiple endocrine neoplasia type 1 are rapidly degraded via the ubiquitin-proteasome pathway. Mol Cell Biol 24: 6569–6580. 32. Farley SM, Chen G, Guo S, Wang M, A J, et al. (2006) Menin localizes to chromatin through an ATR-CHK1 mediated pathway after UV-induced DNA damage. J Surg Res 133: 29–37. 33. Fu XD, Maniatis T (1992) Isolation of a complementary DNA that encodes the mammalian splicing factor SC35. Science 256: 535–538. 34. Espinosa JM, Verdun RE, Emerson BM (2003) p53 functions through stress- and promoter-specific recruitment of transcription initiation components before and after DNA damage. Mol Cell 12: 1015–1027. 35. Mintz PJ, Patterson SD, Neuwald AF, Spahr CS, Spector DL (1999) Purification and biochemical characterization of interchromatin granule clusters. EMBO J 18: 4308–4320. 36. Efrat S, Linde S, Kofod H, Spector D, Delannoy M, et al. (1988) Beta-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene. Proc Natl Acad Sci U S A 85: 9037–9041. 37. Smogorzewska A, Matsuoka S, Vinciguerra P, McDonald ER, 3rd, Hurov KE, et al. (2007) Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair. Cell 129: 289–301. 38. Chakrabarti SK, James JC, Mirmira RG (2002) Quantitative assessment of gene targeting in vitro and in vivo by the pancreatic transcription factor, Pdx1. Importance of chromatin structure in directing promoter binding. J Biol Chem 277: 13286–13293. 39. Donner AJ, Szostek S, Hoover JM, Espinosa JM (2007) CDK8 is a stimulus- specific positive coregulator of p53 target genes. Mol Cell 27: 121–133. PLoS ONE | www.plosone.org 12 January 2011 | Volume 6 | Issue 1 | e16119